SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence
6 references·16 citing·40 second hop
Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence (2014)Patient-Oncologist Cost Communication, Fi…The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)The Financial Toxicity of Can…Financial toxicity, Part I: a new name for a growing problem. (2013)Financial toxicity, Part I: a…Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)Cost Sharing and Adherence to…National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008 (2011)National Estimates of Out-of-…American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)American Society of Clinical …Cost of Cancer Care: Issues and Implications (2007)Cost of Cancer Care: Issues a…Financial toxicity in cancer care in India: a systematic review (2021)Financial toxicity in cancer …The psychosocial cost burden of cancer: A systematic literature review (2020)The psychosocial cost burden …Medical Financial Hardship Intensity and Financial Sacrifice Associated with Cancer in the United States (2020)Medical Financial Hardship In…The Impact of Financial Toxicity on Psychological Well-Being, Coping Self-Efficacy, and Cost-Coping Behaviors in Young Adults with Cancer (2019)The Impact of Financial Toxic…Medical financial hardship among cancer survivors in the United States (2019)Medical financial hardship am…Financial toxicity in gynecologic oncology (2019)Financial toxicity in gynecol…Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared (2019)Financial Toxicity in Advance…Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance (2018)Financial Toxicity in Adults …Financial toxicity and implications for cancer care in the era of molecular and immune therapies (2018)Financial toxicity and implic…Costs of cancer along the care continuum: What we can expect based on recent literature (2018)Costs of cancer along the car…Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States (2017)Do cancer survivors change th…Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters (2017)Discussing Health Care Expens…What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits (2016)What Strategies Do Physicians…Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer (2016)Relationships Among Financial…A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment (2016)A review of cost communicatio…Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study (2015)Financial toxicity in insured…Association of Insurance with Cancer Care Utilization and Outcomes (2008)Financial Burden Of Health Care, 2001–2004 (2008)Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer (2016)Pilot Feasibility Study of an Oncology Financial Navigation Program (2017)The Out-of-Pocket Cost Burden of Cancer Care—A Systematic Literature Review (2021)The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors (2018)Financial toxicity and employment status in cancer survivors. A systematic literature review (2020)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts (2013)Population-Based Assessment of Cancer Survivors' Financial Burden and Quality of Life: A Prospective Cohort Study (2015)The high price of anticancer drugs: origins, implications, barriers, solutions (2017)Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes (2019)Prospect Theory: An Analysis of Decision under Risk (1979)Prospect theory: An analysis of decision under risk (1988)Health Care Disparities (2003)Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006 (2010)The High Cost of Cancer Drugs and What We Can Do About It (2012)Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications (2019)Medical Care Costs: How Much Welfare Loss? (1992)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis (2012)For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships (2016)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries (2014)Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer (2018)Financial toxicity in cancer care: origins, impact, and solutions (2021)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey (2019)Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review (2020)Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Financial Toxicity and Equitable Access to Clinical Trials (2019)Financial Toxicity Among Patients With Breast Cancer Worldwide (2023)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation (2019)Association of Medical Financial Hardship and Mortality Among Cancer Survivors in the United States (2022)
this work references cited by second hop

References

  • 2013The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience1,133 cited
  • 2009American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care638 cited
  • 2013Financial toxicity, Part I: a new name for a growing problem.502 cited
  • 2013Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia500 cited
  • 2007Cost of Cancer Care: Issues and Implications353 cited
  • 2011National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008271 cited

Cited by

  • 2015Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study216 cited
  • 2018Financial toxicity and implications for cancer care in the era of molecular and immune therapies214 cited
  • 2018Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance189 cited
  • 2019Medical financial hardship among cancer survivors in the United States174 cited
  • 2020Medical Financial Hardship Intensity and Financial Sacrifice Associated with Cancer in the United States149 cited
  • 2016A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment147 cited
  • 2019Financial toxicity in gynecologic oncology136 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2016
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer
116 cited
  • 2021Financial toxicity in cancer care in India: a systematic review115 cited
  • 2018Costs of cancer along the care continuum: What we can expect based on recent literature95 cited
  • 2019The Impact of Financial Toxicity on Psychological Well-Being, Coping Self-Efficacy, and Cost-Coping Behaviors in Young Adults with Cancer95 cited
  • 2016What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits91 cited
  • 2020The psychosocial cost burden of cancer: A systematic literature review86 cited
  • 2017Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States84 cited
  • 2017Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters82 cited
  • 2019Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared78 cited